WO2001098340A3 - Regulation of human mast cell protease 6-like enzyme - Google Patents

Regulation of human mast cell protease 6-like enzyme Download PDF

Info

Publication number
WO2001098340A3
WO2001098340A3 PCT/EP2001/007002 EP0107002W WO0198340A3 WO 2001098340 A3 WO2001098340 A3 WO 2001098340A3 EP 0107002 W EP0107002 W EP 0107002W WO 0198340 A3 WO0198340 A3 WO 0198340A3
Authority
WO
WIPO (PCT)
Prior art keywords
mast cell
human mast
cell protease
enzyme
regulation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/EP2001/007002
Other languages
French (fr)
Other versions
WO2001098340A2 (en
Inventor
Yonghong Xiao
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer AG
Original Assignee
Bayer AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer AG filed Critical Bayer AG
Priority to EP01951617A priority Critical patent/EP1297157A2/en
Priority to AU2001272497A priority patent/AU2001272497A1/en
Publication of WO2001098340A2 publication Critical patent/WO2001098340A2/en
Publication of WO2001098340A3 publication Critical patent/WO2001098340A3/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Reagents which regulate human mast cell protease 6-like enzyme activity and reagents which bind to human mast cell protease 6-like enzyme gene products can be used to regulate human mast cell protease 6-like enzyme activity. Such regulation is particularly useful for treating metastasis of malignant cells, tumor angiogenesis, inflammation including asthma, atherosclerosis, neurodegenerative diseases, and pathogenic infections.
PCT/EP2001/007002 2000-06-23 2001-06-21 Regulation of human mast cell protease 6-like enzyme Ceased WO2001098340A2 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
EP01951617A EP1297157A2 (en) 2000-06-23 2001-06-21 Regulation of human mast cell protease 6-like enzyme
AU2001272497A AU2001272497A1 (en) 2000-06-23 2001-06-21 Regulation of human mast cell protease 6-like enzyme

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US21358900P 2000-06-23 2000-06-23
US60/213,589 2000-06-23

Publications (2)

Publication Number Publication Date
WO2001098340A2 WO2001098340A2 (en) 2001-12-27
WO2001098340A3 true WO2001098340A3 (en) 2002-06-06

Family

ID=22795691

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2001/007002 Ceased WO2001098340A2 (en) 2000-06-23 2001-06-21 Regulation of human mast cell protease 6-like enzyme

Country Status (3)

Country Link
EP (1) EP1297157A2 (en)
AU (1) AU2001272497A1 (en)
WO (1) WO2001098340A2 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2003250830A1 (en) * 2002-06-12 2003-12-31 Bayer Healthcare Ag Regulation of human subtilase-like serine protease
JP5189082B2 (en) 2006-05-25 2013-04-24 バイエル・ファルマ・アクチェンゲゼルシャフト Dimeric molecular complex
CA2699513C (en) 2007-09-12 2018-03-13 Novartis Ag Gas57 mutant antigens and gas57 antibodies
PL2235046T3 (en) 2007-12-21 2012-12-31 Novartis Ag Mutant forms of streptolysin o
CN102481349B (en) 2009-01-12 2014-10-15 诺华股份有限公司 Cna_B Domain in Vaccines Against Gram-Positive Bacteria

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998033812A1 (en) * 1997-02-05 1998-08-06 Brigham And Women's Hospital, Inc. Mast cell protease peptide inhibitors
WO1999060139A1 (en) * 1998-05-15 1999-11-25 Promega Corporation ENZYMATICALLY-ACTIVE RECOMBINANT HUMAN β-TRYPTASE AND METHOD OF MAKING SAME
WO2001070978A2 (en) * 2000-03-20 2001-09-27 Curagen Corporation Polypeptides and nucleic acids encoding same

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998033812A1 (en) * 1997-02-05 1998-08-06 Brigham And Women's Hospital, Inc. Mast cell protease peptide inhibitors
WO1999060139A1 (en) * 1998-05-15 1999-11-25 Promega Corporation ENZYMATICALLY-ACTIVE RECOMBINANT HUMAN β-TRYPTASE AND METHOD OF MAKING SAME
WO2001070978A2 (en) * 2000-03-20 2001-09-27 Curagen Corporation Polypeptides and nucleic acids encoding same

Non-Patent Citations (6)

* Cited by examiner, † Cited by third party
Title
BURGESS L E: "Mast cell tryptase as a target for drug design", DRUG NEWS AND PERSPECTIVES, vol. 13, no. 3, 2000, pages 147 - 157, XP000986039, ISSN: 0214-0934 *
DATABASE EM_HUM EMBL; 23 September 1998 (1998-09-23), LLOYD C: "Human DNA sequence from clone LA16-303A1 on chromosome 16", XP002194597 *
HUANG C ET AL.: "Regulation and function of mast cell proteases in inflammation", JOURNAL OF CLINICAL IMMUNOLOGY, vol. 18, no. 3, May 1998 (1998-05-01), pages 169 - 183, XP000990876, ISSN: 0271-9142 *
PALLAORO M ET AL.: "Characterization of genes encoding known and novel human mast cell tryptases on chromosome 16p13.3", JOURNAL OF BIOLOGICAL CHEMISTRY, vol. 274, no. 6, 5 February 1999 (1999-02-05), pages 3355 - 3362, XP002177260, ISSN: 0021-9258 *
REYNOLDS D S ET AL.: "Cloning of the cDNA and gene of mouse mast cell protease-6. Transcription by progenitor mast cells of the connective tissue subclass", JOURNAL OF BIOLOGICAL CHEMISTRY, vol. 266, no. 6, 25 February 1991 (1991-02-25), pages 3847 - 3853, XP002934402, ISSN: 0021-9258 *
WALLS A F ET AL.: "Production and characterization of monoclonal antibodies specific for human mast cell tryptase", CLINICAL AND EXPERIMENTAL ALLERGY, vol. 20, no. 5, 1 September 1990 (1990-09-01), pages 581 - 589, XP000647681, ISSN: 0954-7894 *

Also Published As

Publication number Publication date
WO2001098340A2 (en) 2001-12-27
EP1297157A2 (en) 2003-04-02
AU2001272497A1 (en) 2002-01-02

Similar Documents

Publication Publication Date Title
WO2001096538A3 (en) Regulation of human transmembrane serine protease
DE60043443D1 (en) PHYTASE ENZYMES, CODUCTIVE NUCLEIC ACIDS, AND SUCH VECTORS AND HOST CELLS
WO2002008392A3 (en) Regulation of human matriptase-like serine protease
WO2001098340A3 (en) Regulation of human mast cell protease 6-like enzyme
WO2001096378A3 (en) Human epithin-like serine protease
WO2001098466A3 (en) Regulation of human prostasin-like serine protease
WO2001098467A3 (en) Regulation of human prostasin-like serine protease
AU2826801A (en) Surface modified supporting materials for binding biological materials, method for the production and use thereof
AU2003259761A1 (en) Enhancement of adenoviral oncolytic activity in prostate cells by modification of the e1a gene product
WO2001072973A3 (en) Regulation of human heparanase-like enzyme
AU2410200A (en) Protein engineering of glucoamylase to increase ph optimum, substrate specificity and thermostability
WO2002000702A3 (en) Regulation of human epidermis-specific serine protease
AU2001283872A1 (en) Regulation of human eosinophil serine protease 1-like enzyme
WO2001085959A3 (en) Regulation of human lysostaphin-like protease
WO2001066766A3 (en) A matrix metalloproteinase (mmp-25) expressed in skin cell
WO2001059102A3 (en) Nucleozymes with endonuclease activity
WO2001062941A3 (en) Regulation of human gelatinase b-like enzyme 2
WO2002007681A3 (en) Sunscreen formulations containing nucleic acids
WO2002024886A3 (en) Regulation of human serine protease
WO2002026957A3 (en) Regulation of a human serine protease
WO2001042431A3 (en) Regulation of human mitochondrial deformylase
AU2001264245A1 (en) Novel enzyme gene and its expression product
AU6424501A (en) Novel enzyme gene and its expression product
WO2002010203A3 (en) Daz genes
DE50008686D1 (en) LYTIC ENZYME

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
121 Ep: the epo has been informed by wipo that ep was designated in this application
AK Designated states

Kind code of ref document: A3

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

WWE Wipo information: entry into national phase

Ref document number: 2001951617

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 10311955

Country of ref document: US

WWP Wipo information: published in national office

Ref document number: 2001951617

Country of ref document: EP

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

NENP Non-entry into the national phase

Ref country code: JP

WWR Wipo information: refused in national office

Ref document number: 2001951617

Country of ref document: EP

WWW Wipo information: withdrawn in national office

Ref document number: 2001951617

Country of ref document: EP